![Walter Lawrence, 95, reflects on the National Cancer Act, medicine, social justice, COVID-19, and Richmond's vanishing monuments](https://cdn.cancerletter.com/media/2020/08/23163630/32-summer-web_4x3.jpg)
![Walter Lawrence, 95, reflects on the National Cancer Act, medicine, social justice, COVID-19, and Richmond's vanishing monuments](https://cdn.cancerletter.com/media/2020/08/23163630/32-summer-web_4x3.jpg)
Cover Story
Conversation with The Cancer LetterCOVID-19 & CancerFree
In 1971, when the National Cancer Act was signed, Walter Lawrence, Jr., was one of the surgeons eager for a push forward, driven by rigorous science reviewed and funded by the federal government.
NCI Trials
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
NCI Trials for August 2020
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Proposed rule by CMS would expand access to cancer treatment at tribal facilities
- Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.” - A view from the BMT unit on the day a Russian cruise missile hit Kyiv’s Ohmatdyt hospital